Indaptus Therapeutics, Inc.INDPNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank79
5Y CAGR-26.8%
Year-over-Year Change
Year-over-year free cash flow growth rate
5Y CAGR
-26.8%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
3 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 8.07% |
| 2023 | -1.17% |
| 2022 | -17.32% |
| 2021 | -239.72% |
| 2020 | 88.91% |
| 2019 | 38.44% |
| 2018 | -79.39% |
| 2017 | -117.29% |
| 2016 | -34.01% |
| 2015 | -93.02% |